Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.

More search options...

Milicic, D; Ben Avraham, B; Chioncel, O; Barac, YD; Goncalvesova, E; Grupper, A; Altenberger, J; Frigeiro, M; Ristic, A; De Jonge, N; et al. Milicic, D; Ben Avraham, B; Chioncel, O; Barac, YD; Goncalvesova, E; Grupper, A; Altenberger, J; Frigeiro, M; Ristic, A; De Jonge, N; Tsui, S; Lavee, J; Rosano, G; Crespo-Leiro, MG; Coats, AJS; Seferovic, P; Ruschitzka, F; Metra, M; Anker, S; Filippatos, G; Adamopoulos, S; Abuhazira, M; Elliston, J; Gotsman, I; Hamdan, R; Hammer, Y; Hasin, T; Hill, L; Itzhaki Ben Zadok, O; Mullens, W; Nalbantgil, S; Piepoli, MF; Ponikowski, P; Potena, L; Ruhparwar, A; Shaul, A; Tops, LF; Winnik, S; Jaarsma, T; Gustafsson, F; Ben Gal, T (2021) Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department. ESC Heart Fail, 8 (6). pp. 4409-4424. ISSN 2055-5822 https://doi.org/10.1002/ehf2.13587
SGUL Authors: Rosano, Giuseppe Massimo Claudio

Preview

PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (291kB) | Preview

Official URL: https://doi.org/10.1002/ehf2.13587

Abstract

The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of those patients to present to the emergency department with expected and non-expected device-related and patient-device interaction complications. The ageing of the LVAD-supported patients, mainly those supported with the 'destination therapy' indication, increases the risk for those patients to suffer from other co-morbidities common in the older population. In this second part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, definitions and structured approach to the LVAD-supported patient presenting to the emergency department with bleeding, neurological event, pump thrombosis, chest pain, syncope, and other events are presented. The very challenging issue of declaring death in an LVAD-supported patient, as the circulation is artificially preserved by the device despite no other signs of life, is also discussed in detail.

Item Type:

Article

Additional Information:

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Keywords:

Bleeding, Death declaration, Emergency department, LVAD, Neurological events, LVAD, Emergency department, Bleeding, Neurological events, Death declaration

SGUL Research Institute / Research Centre:

Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)

Journal or Publication Title:

ESC Heart Fail

ISSN:

2055-5822

Language:

eng

Dates: